4.3 Review

The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases

期刊

EXPERT REVIEW OF CLINICAL IMMUNOLOGY
卷 10, 期 5, 页码 593-619

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/1744666X.2014.894886

关键词

CXCL8; clinical trials; CXCR1; chemoattractants; infection; acute and chronic inflammation; CXCR2

资金

  1. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq
  2. Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG
  3. European Community [HEALTH-F4-2011-281608]

向作者/读者索取更多资源

Chemokines are small proteins that control several tissue functions, including cell recruitment and activation under homeostatic and inflammatory conditions. CXCL8 (interleukin-8) is a member of the chemokine family that acts on CXCR1 and CXCR2 receptors. CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL7 are also ELR+ chemokine members that bind to these receptors, especially CXCR2. The majority of studies on the biology of CXCL8 and their receptors have been performed in polymorphonuclear leukocytes. However, many other cells express CXCR1/CXCR2, including epithelial, endothelial, fibroblasts and neurons, contributing to the biological effects of CXCL8. There is substantial amount of experimental data suggesting that CXCL8 and receptors contribute to elimination of pathogens, but may also contribute significantly to disease-associated processes, including tissue injury, fibrosis, angiogenesis and tumorigenesis. Here, we discuss the biology of CXCL8 family and the potential therapeutic use of antagonists or blockers of these molecules in the context of organ-specific diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据